Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination
- 24 September 2009
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 16 (12), 3227-3236
- https://doi.org/10.1245/s10434-009-0706-z
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study GroupJournal of Clinical Oncology, 2006
- Efficacy of S-1 for Patients with Peritoneal Metastasis of Gastric CancerChemotherapy, 2006
- Neoadjuvant treatment of gastric cancer with peritoneal disseminationEuropean Journal of Surgical Oncology, 2006
- Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combinationGastric Cancer, 2006
- Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusionBritish Journal of Surgery, 2005
- Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional StudyJournal of Clinical Oncology, 2004
- Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatinGastric Cancer, 2004
- TNM residual tumor classification revisitedCancer, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000